Financial Ratios

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE131.105.95 (+4.75 %)
PREV CLOSE ( ) 125.15
OPEN PRICE ( ) 130.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2304
TODAY'S LOW / HIGH ( )126.40 132.70
52 WK LOW / HIGH ( )60.1 147.7
NSE131.756.65 (+5.32 %)
PREV CLOSE( ) 125.10
OPEN PRICE ( ) 126.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 131.75 (110)
VOLUME 42098
TODAY'S LOW / HIGH( ) 124.30 132.85
52 WK LOW / HIGH ( )60.65 148.8
Select year
ParticularsMar2020Mar2019Mar2018Mar2017Mar2016
Operational & Financial Ratios
   Earnings Per Share (Rs)-16.04-12.03-12.97-11.68-12.49
   CEPS(Rs)-13.44-9.39-9.61-8.30-8.75
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-18.14-8.59-12.941.077.15
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-55.53-20.44-22.21-226.62-879.85
   EBIT Margin(%)-68.44-28.74-37.48-355.81-1105.40
   Pre Tax Margin(%)-86.41-41.90-52.77-454.63-1157.81
   PAT Margin (%)-86.41-41.90-52.77-454.63-1157.81
   Cash Profit Margin (%)-72.41-32.68-40.48-334.70-839.55
Performance Ratios
   ROA(%)-20.91-14.92-14.38-13.46-14.60
   ROE(%)0.000.000.00-296.70-683.34
   ROCE(%)-56.95-35.41-28.95-27.13-25.38
   Asset Turnover(x)0.240.360.270.030.01
   Sales/Fixed Asset(x)0.140.210.150.020.01
   Working Capital/Sales(x)-1.38-2.00-1.35-0.19-0.07
Efficiency Ratios
   Fixed Capital/Sales(x)7.154.866.7562.29134.82
   Receivable days17.0012.3610.3483.5551.87
   Inventory Days130.8779.0792.84573.341435.63
   Payable days149.00123.16120.44290.43338.13
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-6.09-12.36-16.49-11.65-11.59
   Price/Book(x)-4.52-13.50-12.6993.2014.68
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)6.394.798.3352.43129.87
   EV/Core EBITDA(x)-11.74-24.27-38.56-23.35-14.73
   EV/EBIT(x)-9.33-16.68-22.22-14.73-10.75
   EV/CE(x)1.601.612.241.521.44
   M Cap / Sales4.414.046.6838.99106.37
Growth Ratio
   Net Sales Growth(%)-30.0441.38856.86173.74
   Core EBITDA Growth(%)-92.84-29.297.9430.32-132.51
   EBIT Growth(%)-66.63-8.41-0.7919.39-308.80
   PAT Growth(%)-44.28-12.27-11.061.66-108.17
   EPS Growth(%)-33.307.22-11.066.53-51.60
Financial Stability Ratios
   Total Debt/Equity(x)-2.03-3.74-3.1632.193.27
   Current Ratio(x)0.440.560.410.410.32
   Quick Ratio(x)0.090.400.130.240.13
   Interest Cover(x)-3.81-2.18-2.45-3.60-21.09
   Total Debt/Mcap(x)0.450.280.250.350.22

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)